Deracoxib
Title: Deracoxib
CAS Registry Number: 169590-41-4
CAS Name: 4-[3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]benzenesulfonamide
Manufacturers' Codes: SC-046; SC-59046
Trademarks: Deramaxx (Novartis)
Molecular Formula: C17H14F3N3O3S
Molecular Weight: 397.37
Percent Composition: C 51.38%, H 3.55%, F 14.34%, N 10.57%, O 12.08%, S 8.07%
Literature References: Selective cyclooxygenase-2 (COX-2) inhibitor. Prepn: J. J. Talley et al., WO 9515316; M. J. Graneto, US 5521207 (1995, 1996 both to Searle); T. D. Penning et al., J. Med. Chem. 40, 1347 (1997). Structure activity study: G. R. Desiraju et al., Molecules 5, 945 (2000). Effect in experimental synovitis in dogs: D. L. Millis et al, Vet. Ther. 3, 453 (2002); HPLC determn in plasma: S. K. Cox et al., J. Chromatogr. B 819, 181 (2005).
Properties: Light tan solid, mp 159-161°.
Melting point: mp 159-161°
Therap-Cat-Vet: Anti-inflammatory; analgesic.

Others monographs:
DINPPimpinellinAcediasulfoneNeptunium
Inosine PranobexNybomycinIndospicineDurohydroquinone
Gallium NitrideLazuriteMofezolacZein
QuinboloneCyclodextrinsAzamethonium BromidePlasmin
©2016 DrugLead US FDA&EMEA